BioCentury | Mar 7, 2005
Company News

Osel, Miyarisan deal

...Osel received exclusive North American and European commercialization rights to Miyarisan's MIYA-BM , a tablet that...
...to treat and prevent antibiotic-induced gastrointestinal disorders including C. difficile associated disease and antibiotic-associated diarrhea. Miyarisan...
...for Europe in 2006. MIYA-BM is approved in Japan. Osel Inc. , Santa Clara, Calif. Miyarisan Pharmaceutical Co. Ltd....
BioCentury | Mar 3, 2005
Company News

Osel, Miyarisan in GI deal

...Osel (Santa Clara, Calif.) received exclusive North American and European commercialization rights to Miyarisan's MIYA-BM...
...to treat and prevent antibiotic-induced gastrointestinal disorders including C. difficile associated disease and antibiotic-associated diarrhea. Miyarisan...
Items per page:
1 - 2 of 2
BioCentury | Mar 7, 2005
Company News

Osel, Miyarisan deal

...Osel received exclusive North American and European commercialization rights to Miyarisan's MIYA-BM , a tablet that...
...to treat and prevent antibiotic-induced gastrointestinal disorders including C. difficile associated disease and antibiotic-associated diarrhea. Miyarisan...
...for Europe in 2006. MIYA-BM is approved in Japan. Osel Inc. , Santa Clara, Calif. Miyarisan Pharmaceutical Co. Ltd....
BioCentury | Mar 3, 2005
Company News

Osel, Miyarisan in GI deal

...Osel (Santa Clara, Calif.) received exclusive North American and European commercialization rights to Miyarisan's MIYA-BM...
...to treat and prevent antibiotic-induced gastrointestinal disorders including C. difficile associated disease and antibiotic-associated diarrhea. Miyarisan...
Items per page:
1 - 2 of 2